Table 3 Percentage of medication during the follow-up period
Medications | At baseline | P-value | At the end of study | P-value | ||
|---|---|---|---|---|---|---|
Control | Intervention | Control | Intervention | |||
(n = 208) | (n = 234) | (n = 184) | (n = 203) | |||
Mean of number of antihypertensive medications | 2.0 ± 0.5 | 2.2 ± 0.4 | 0.06 | 1.8 ± 0.4 | 2.7 ± 0.5 | 0.05 |
Mean of number of glucose-lowering medications | 0.8 ± 0.2 | 1.1 ± 0.3 | 0.08 | 0.6 ± 0.1 | 1.7 ± 0.3 | 0.24 |
Insulin (%) | 16.9 | 21.1 | 0.10 | 16.9 | 28.4 | 0.01 |
ACEi/ARBs use (%) | 91.3 | 85 | 0.05 | 88.9 | 92.7 | 0.09 |
Statins use (%) | 75.5 | 71.4 | 0.33 | 75 | 82.9 | 0.11 |
Antiplatelets use (%) | 63.9 | 36.3 | 0.05 | 55.8 | 36.3 | 0.12 |
NSAIDs (%) | 15.4 | 19.2 | 0.09 | 6.5 | 7.7 | 0.18 |